Failure of DDAVP to shorten the prolonged bleeding time of two patients with congenital afibrinogenemia
Authors:
- Francesco RodeghieroFRFrancesco Rodeghiero
- 1 November 1992
- journal article
- case report
- Published by Elsevier in Thrombosis Research
- Vol. 68 (3) , 309-315
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand diseaseBlood Reviews, 1991
- Platelet von Willebrand factor assay: results using two methods for platelet lysisThrombosis Research, 1990
- Glanzmann's thrombasthenia: the spectrum of clinical diseaseBlood, 1990
- Von Willebrand Factor Antigen Is Less Sensitive than Ristocetin Cofactor for the Diagnosis of Type I von Willebrand Disease -Results Based on an Epidemiological InvestigationThrombosis and Haemostasis, 1990
- Use of DDAVP in inherited and acquired platelet dysfunctionAmerican Journal of Hematology, 1990
- DDAVP shortens the bleeding time in bernard-soulier syndromeThrombosis Research, 1988
- 1-Desamino-8-D-arginine Vasopressin (Desmopressin) Shortens the Bleeding Time in Storage Pool DeficiencyAnnals of Internal Medicine, 1988
- Ddavp-induced correction of prolonged bleeding time in patients with congenital platelet function defectsThrombosis Research, 1987
- Quantitative determination of human fibrinogen in plasma following carbamylation by laurell electrophoresis in antibody containing gelClinica Chimica Acta, 1971
- Fibrinogen and Platelets in the Primary Arrest of BleedingNew England Journal of Medicine, 1971